Poster Title

Targeted Combination Therapy Improves Erdafitinib Efficacy in Urothelial Cancer

Authors

Omotola Deborah Ogundipe, Howard UniversityFollow
Esther Julia Beck, University of ChicagoFollow
Mohamad Karim Koleilat, The University of Texas MD Anderson Cancer Center
Lawrence Kwong, The University of Texas MD Anderson Cancer Center

Files

Keywords

Erdafitinib, Sel120, Urothelial cancer, Synergism

Program Affiliation

Partnership for Careers in Cancer Science and Medicine

Recommended Citation

Ogundipe, Omotola Deborah; Beck, Esther Julia; Koleilat, Mohamad Karim; and Kwong, Lawrence, "Targeted Combination Therapy Improves Erdafitinib Efficacy in Urothelial Cancer" (2022). Summer Experience 2022. 31.
https://openworks.mdanderson.org/sumexp22/31